Literature DB >> 24708232

Telephone counseling and home telehealth monitoring to improve medication adherence: results of a pilot trial among individuals with multiple sclerosis.

Aaron P Turner1, Alicia P Sloan1, Daniel R Kivlahan1, Jodie K Haselkorn1.   

Abstract

OBJECTIVE: To evaluate the impact upon medication adherence of brief telephone-based counseling using principles of motivational interviewing and telehealth home monitoring.
DESIGN: Randomized controlled pilot trial of 19 veterans with multiple sclerosis (MS) currently prescribed disease modifying therapy (DMT) who endorsed missing doses. Follow-up was conducted at 1, 3, and 6 months.
RESULTS: Participants in the intervention condition reported better adherence relative to controls at 6-month follow-up [M (SD) = 1.3 (2.1) vs. 8.2 (12.3) past month missed doses]. All participants in the intervention condition completed all 3 telephone counseling sessions and 90% or greater rated the program as highly successful.
CONCLUSION: Brief telephone counseling represents a promising mechanism for improving medication adherence. The primary components, motivational interviewing and home telehealth monitoring, provided complementary mechanisms for initiating and sustaining behavior change over time. The intervention was well tolerated and provided an opportunity to extend access and reduce barriers to care by bringing it into the homes of participants. (c) 2014 APA, all rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24708232     DOI: 10.1037/a0036322

Source DB:  PubMed          Journal:  Rehabil Psychol        ISSN: 0090-5550


  12 in total

1.  Telemedicine in Neurological Disorders: Opportunities and Challenges.

Authors:  Martina Chirra; Luca Marsili; Linsdey Wattley; Leonard L Sokol; Elizabeth Keeling; Simona Maule; Gabriele Sobrero; Carlo Alberto Artusi; Alberto Romagnolo; Maurizio Zibetti; Leonardo Lopiano; Alberto J Espay; Ahmed Z Obeidat; Aristide Merola
Journal:  Telemed J E Health       Date:  2018-08-23       Impact factor: 3.536

2.  Investigating the Impact of the TUITEK® Patient Support Programme, Designed to Support Caregivers of Children Prescribed Recombinant Human Growth Hormone Treatment in Taiwan.

Authors:  Pen-Hua Su; Sumaira Malik; Amrit Jheeta; Yen-Fan Lin; Su-Huei Su; Ekaterina Koledova; Selina Graham
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-06       Impact factor: 6.055

Review 3.  Adherence to r-hGH Therapy in Pediatric Growth Hormone Deficiency: Current Perspectives on How Patient-Generated Data Will Transform r-hGH Treatment Towards Integrated Care.

Authors:  Martin O Savage; Luis Fernandez-Luque; Selina Graham; Paula van Dommelen; Matheus Araujo; Antonio de Arriba; Ekaterina Koledova
Journal:  Patient Prefer Adherence       Date:  2022-07-11       Impact factor: 2.314

4.  Cognitive Behavioral Therapy for the Management of Multiple Sclerosis-Related Pain: A Randomized Clinical Trial.

Authors:  Elizabeth S Gromisch; Robert D Kerns; Rebecca Czlapinski; Beth Beenken; John Otis; Albert C Lo; John Beauvais
Journal:  Int J MS Care       Date:  2020 Jan-Feb

5.  Behavioral Interventions in Multiple Sclerosis.

Authors:  Aaron P Turner; Lindsey M Knowles
Journal:  Fed Pract       Date:  2020-04

6.  Persistence and adherence in multiple sclerosis patients starting glatiramer acetate treatment: assessment of relationship with care received from multiple disciplines.

Authors:  Peter Joseph Jongen; Wim A Lemmens; Raymond Hupperts; Erwin Lj Hoogervorst; Hans M Schrijver; Astrid Slettenaar; Els L de Schryver; Jan Boringa; Esther van Noort; Rogier Donders
Journal:  Patient Prefer Adherence       Date:  2016-05-24       Impact factor: 2.711

7.  Patient adherence to subcutaneous IFN beta-1a injections using the RebiSmart® injection device: a retrospective real-world study among Dutch and German patients with multiple sclerosis.

Authors:  Marieke Krol; Gert de Voer; Ulrike Osowski
Journal:  Patient Prefer Adherence       Date:  2017-07-11       Impact factor: 2.711

8.  Designing a Personalized Digital Patient Support Program for Patients Treated With Growth Hormone: Key Design Considerations.

Authors:  Sumaira Malik; Clare Moloney; Ekaterina Koledova; Jonathan Reston; John Weinman
Journal:  J Med Internet Res       Date:  2020-07-29       Impact factor: 5.428

Review 9.  Telehealth in Multiple Sclerosis Clinical Care and Research.

Authors:  Xinran Maria Xiang; Jacqueline Bernard
Journal:  Curr Neurol Neurosci Rep       Date:  2021-02-28       Impact factor: 5.081

Review 10.  Mobile health (mHealth) usage, barriers, and technological considerations in persons with multiple sclerosis: a literature review.

Authors:  Elizabeth S Gromisch; Aaron P Turner; Jodie K Haselkorn; Albert C Lo; Thomas Agresta
Journal:  JAMIA Open       Date:  2020-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.